Research reveals combination therapy improves management of intrahepatic cholangiocarcinoma, addressing drug resistance.
In summary, ICIs are assuming an increasingly prominent role in the management of ICC. Efforts should be made to improve treatment methods and apply combination therapy strategies to address drug resistance. The combination of multiple treatment methods and ongoing research are crucial for addressing the treatment of ICC.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: